Skip to content
FY'24
Revenue (Gross) by Business
Compute Services And Treasury Management$0
Drug Discovery Services$84.81K
Net Income Loss Excluding Discontinued Operations by Business
Compute Services And Treasury Management$0
Drug Discovery Services-$4.25M
Segment Reporting Other Item Amount by Business
Compute Services And Treasury Management$0
Drug Discovery Services-$606
Operating Income by Business
Compute Services And Treasury Management$0
Drug Discovery Services-$4.25M
Selling And Marketing Expense by Business
Compute Services And Treasury Management$0
Drug Discovery Services$5
Cost of Goods Sold by Business
Compute Services And Treasury Management$0
Drug Discovery Services$78.29K
Segment Expenditure Addition To Long Lived Assets by Business
Compute Services And Treasury Management$0
Drug Discovery Services$3.03K
Research And Development Expense by Business
Compute Services And Treasury Management$0
Drug Discovery Services$2.23M
Depreciation And Amortization by Business
Compute Services And Treasury Management$0
Drug Discovery Services$124.94K
General And Administrative Expense by Business
Compute Services And Treasury Management$0
Drug Discovery Services$2.02M

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Axe Compute Inc. Common Stock break its business down?
Axe Compute Inc. Common Stock (AGPU) reports revenue (gross) by business across 2 parts — Compute Services And Treasury Management and Drug Discovery Services. Each is extracted from the segment footnotes and tracked over time.
Where does Axe Compute Inc. Common Stock's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Axe Compute Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.